Astellas Oncology – 2022 C3 (Changing Cancer Care) Prize Grand Prize Winner

The Astellas Oncology C3 (Changing Cancer Care) Prize is a global challenge that funds and advances the best non-treatment ideas to improve cancer care for patients, caregivers and the broader oncology community. This year’s Grand Prize winner is Aimee DeGolyer, Founder and CEO of REPROSENT, who will receive a $100,000 grant plus additional resources and hands-on support. She talks about losing her father in 2020 to a cancer immunotherapy adverse reaction, which inspired her to build a system that helps patients and their caregivers track symptom data and triage challenging symptoms with a focus on reducing clinical team burden and improving outcomes. As an experienced start-up professional, she also shares advice for how healthcare entrepreneurs can bring their big ideas to life.

Aimee DeGolyer is the Founder and CEO of REPROSENT, a company that helps cancer patients track their own symptom data and include it in their care for better outcomes. A serial startup person, she has spent her career building new technologies and finding simple solutions to complex problems. Previous companies she has worked at include Ciitizen, an oncology health records company acquired by Invitae, True Key, a biometrics-based password manager sold to a Private Equity firm, OnCue, an over-the-top media player sold to Verizon, and Lightlogic, a high-speed optical transceiver company sold to Intel. When not working she enjoys time with her husband and three girls and likes to drag all of them on hikes whenever possible.